Published in Law and Health Weekly, April 8th, 2006
"The inhibition of angiogenesis is a promising strategy for the treatment of malignant primary and secondary tumors in addition to established therapies such as surgery, chemotherapy, and radiation. There is strong experimental evidence in primary tumors that cyclooxygenase-2 (Cox-2) inhibition is a potent mechanism to reduce angiogenesis," scientists in Switzerland report.
"For bone metastases which occur in up to 85% of the most frequent...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.